CHICAGO -- More than three-quarters of HIV patients with a measurable viral load who are receiving care in the United States carry strains of the virus that are resistant to drug therapy, according to findings presented here at the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), sponsored by the American Society for Microbiology. The estimate is among the first for the national HIV population as a whole, and may be higher than expected by many experts.
The above story is based on materials provided by Veterans Affairs. Note: Materials may be edited for content and length.
Cite This Page: